David A Burden

13PUBLICATIONS
58CO-AUTHORS
PharmacogenomicsPredictive and prognostic markersCommunity psychologyGene and molecular therapyToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Apr 30, 2026
Evaluation of a Therapeutic Drug Monitoring Strategy for Adalimumab in Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic Study.

|Jul 17, 2025
Mendelian randomization identifies OX40 as a potential mediator of the effects of cigarette smoking on palmoplantar pustulosis.

Alice Smail, Nick Dand, Xinyue Liu

|Jun 07, 2024
Clinical course, treatment and management of generalised pustular psoriasis from a United Kingdom extension of a global Delphi panel.

Jonathan N Barker, Gabrielle Becher, David A Burden

|Sep 23, 2023
British Association of Dermatologists guidelines for biologic therapy for psoriasis 2023: a pragmatic update.

Catherine H Smith, Zenas Z N Yiu, Tracy Bale

|Sep 21, 2023
Spesolimab Efficacy and Safety in Patients with Moderate-to-Severe Palmoplantar Pustulosis: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase IIb, Dose-Finding Study.

A David Burden, Robert Bissonnette, Alexander A Navarini

|May 04, 2023
Efficacy of spesolimab for the treatment of generalized pustular psoriasis flares across pre-specified patient subgroups in the Effisayil 1 study.

A D Burden, Y Okubo, M Zheng

Pageof 3

Frequent Collaborators

4 joint publications

Jonathan N Barker

4 joint publications

Christopher E M Griffiths

4 joint publications

Nick J Reynolds

3 joint publications

Catherine H Smith